Ionis Pharmaceuticals IONS Investment Purchases
Investment Purchases at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt.
The official record: Ionis Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's investment purchases.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's investment purchases?
- Ionis Pharmaceuticals (IONS) reported investment purchases of $192.76M in Q1 2026.
- How has Ionis Pharmaceuticals's investment purchases changed year-over-year?
- Ionis Pharmaceuticals's investment purchases decreased by 38.0% year-over-year, from $311.07M to $192.76M.
- What is the long-term trend for Ionis Pharmaceuticals's investment purchases?
- Over 4 years (2021 to 2025), Ionis Pharmaceuticals's investment purchases has grown at a 14.3% compound annual growth rate (CAGR), from $1.12B to $1.92B.
- What does investment purchases mean?
- Cash spent to buy financial assets or securities.
- How do you interpret investment purchases?
- High outflows indicate a strategy of deploying excess cash into interest-bearing or strategic assets, while low outflows may suggest limited liquidity or a focus on cash preservation.
- How does investment purchases compare across companies?
- Standard line item for companies with significant cash balances and treasury management functions.